Back to search

University of South Florida

Evolution of Targeted Therapy Resistance in EML4-ALK Positive Non-Small Cell Lung Cancer

Abstract

dc:description

Targeted therapies have emerged as potent treatments that lead to the remission of many tumors. However, they rarely cure cancers in advanced, metastatic settings. This is due to the evolution of resistance, which in turn can be ascribed to the survival of small subpopulations of tolerant and/or resistant cells. Here we investigated the evolution of resistance to EML4-ALK inhibitors in non-small cell lung cancer (NSCLC) and demonstrated that resistance evolves gradually, from unique pre-treatment sub-populations, as multiple resistance mechanisms accumulate in a Darwinian fashion. Despite accumulating multiple changes, cells evolved, in parallel, toward similar inhibitor specific phenotypes. Evolving cells have unique vulnerabilities that can be targeted with collateral sensitivity agents before full resistance evolves. These conclusions, obtained from in vitro studies, are applicable to the evolution of resistance in vivo. However, the evolution of resistance in vivo is also strongly influenced by microenvironmental therapy resistance. These findings could allow physicians to base treatment strategies on the future evolutionary trajectories of tumors and exploit unique vulnerabilities not just after, but during, the evolution of resistance.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Biology (Integrative Biology)
Grantor
University of South Florida
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Vander Velde, Robert
Contributors dc:contributor
  • Andriy Marusyk, Ph.D.
  • Subhra Mohapatra, Ph.D.
  • Robert Deschenes, Ph.D.
  • George Blanck, Ph.D.
  • David Basanta, Ph.D.
  • Sydney Shaffer, M.D., Ph.D.

Subjects

dc:subject × 8

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/9249

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Vander Velde, Robert. Evolution of Targeted Therapy Resistance in EML4-ALK Positive Non-Small Cell Lung Cancer. Dissertation thesis, University of South Florida, 2021. https://digitalcommons.usf.edu/etd/9249